BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 17802961)

  • 1. A Comprehensive Examination of Heterocyclic Scaffold Chemistry for Antitubercular Activity.
    Bendi A; Yadav P; Saini K; Singh Bhathiwal A; Raghav N
    Chem Biodivers; 2024 May; 21(5):e202400067. PubMed ID: 38500408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents.
    Dixit PP; Patil VJ; Nair PS; Jain S; Sinha N; Arora SK
    Eur J Med Chem; 2006 Mar; 41(3):423-8. PubMed ID: 16494970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antituberculosis action of some new pyruvic acid derivatives.
    Ungureanu M; Diculencu D; Archip C
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):860-4. PubMed ID: 20201282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
    Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
    Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel [1,2]-diamines with antituberculosis activity.
    Meng Q; Luo H; Chen Y; Wang T; Yao Q
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antituberculosis activity of new hydrazide derivatives.
    Kaplancikli ZA; Turan-Zitouni G; Ozdemir A; Teulade JC
    Arch Pharm (Weinheim); 2008 Nov; 341(11):721-4. PubMed ID: 18720343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Researches concerning the synthesis and antituberculosis action of some new sulphacetamide derivatives.
    Ungureanu M; Diculencu D; Stirbu CA
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):456-9. PubMed ID: 17802961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antituberculosis drugs: ten years of research.
    Janin YL
    Bioorg Med Chem; 2007 Apr; 15(7):2479-513. PubMed ID: 17291770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzo[c]phenanthridine bases and their antituberculosis activity.
    Ishikawa T
    Med Res Rev; 2001 Jan; 21(1):61-72. PubMed ID: 11135299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early bactericidal activity of antituberculosis agents.
    Donald PR; Sirgel FA; Venter A; Parkin DP; Seifart HI; van de Wal BW; Maritz JS; Fourie PB
    Expert Rev Anti Infect Ther; 2003 Jun; 1(1):141-55. PubMed ID: 15482107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triazole: A Promising Antitubercular Agent.
    Keri RS; Patil SA; Budagumpi S; Nagaraja BM
    Chem Biol Drug Des; 2015 Oct; 86(4):410-23. PubMed ID: 25643871
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.